RYR2 and cardiac hypertrophy: The present study shows that CaMKII inhibitory peptide AC3-I reduced phosphorylation of PLN at Thr-17 in Ryr2+/+ and Ryr2ADA/ADA mice without significantly altering life span, cardiac morphology and performance, or markers of cardiac hypertrophy relative to mice expressing the control peptide.